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Abstract
Background: Present study aimed to better understand the potential apoptotic pathways that involved in
docosahexaenoic acid (DHA)-induced apoptosis of prostate cancer cells.
Methods: Human prostate cancer DU145 cells were treated with different concentrations of fish oil, omega-3 PUFA
(DHA, and Eicosapentaenoic acid, EPA), or omega-6 PUFA (Arachidonic acid, AA). Cell viability and apoptosis were
evaluated by MTT assay and Hoechst staining. Pathway-focused gene expression profiling of DU145 cells was
analyzed with the RT2 Profile PCR Array System. The results were verified by real time quantitative polymerase chain
reaction (RT-qPCR).
Results: AA exposure showed no obvious effect on viability of DU145 cells. However, exposure with fish oil, EPA, or
DHA for 24 h significantly affected cell viability. The growth inhibition of DHA was more pronounced than that of
EPA and showed a time-dependent increase. DHA exposure caused typical apoptotic characteristics. Ten genes
were more expressed, while 5 genes were less expressed following DHA exposure. RT-qPCR confirmed the time
dependent effect of DHA on the expression of these differentially expressed genes. KEGG pathway analysis showed
that DHA may induce the apoptosis of cancer cells preferentially through mediating P53, MAPK, TNF, PI3K/AKT, and
NF-κB signaling pathways.
Conclusion: Our study demonstrated the beneficial action of DHA on human prostate carcinoma cell line DU145.
The pro-apoptotic effect of DHA on DU145 cells may involve mediation various pathways, especially P53, MAPK,
TNF, PI3K/AKT, and NF-κB signaling pathways. Molecular mechanisms of DHA on apoptosis of cancer cells still need
to be further clarified.
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Background
Prostate cancer is one of the most commonly diagnosed
cancers in elderly men, with approximately one million
new cases diagnosed per year worldwide [1]. The inci-
dence of prostate cancer in Asian populations has long
been established to be lower than that in Western popu-
lations. However, the prevalence of the disease has
shown a rapid increase in Asian countries, including
China [2, 3]. More and more cases of prostate cancer
have been diagnosed in China in recent years [4]. In
Shanghai alone, the incidence of prostate cancer has in-
creased from 1.6 to 7.7 per 10,000 person (4.8 folds)
during 1973 to 2000 [5]. One explanation for this rapid
change is the westernization of dietary life style [6].
Compared to Eastern counterpart, the diet of Western
population is generally characterized by higher levels of
saturated fats that may contribute to the development of
prostate cancer [7]. Daily intake of the individual fatty
acids such as omega-3 polyunsaturated fatty acids
(PUFA) has been reported to be comparatively low in
most Westernized countries [8]. Dietary factors, includ-
ing the consumption of unsaturated fat, may reduce the
risk or progression of prostate cancer [9].
Certain omega-3 PUFA, including docosahexaenoic acid
(DHA), have been well recognized to exert beneficial ef-
fects in prevention of a series of chronic diseases, includ-
ing cancer [10]. Dietary fat fish, fish oils and their active
omega-3 PUFAs constituents have been associated with
the reduced risk of prostate cancer [8, 11, 12]. Various
pathways have been reported to involve in the antiprolifera-
tive effects of omega-3 PUFAs in prostate cancer [13–15].
It has been suggested that omega-3 PUFAs may inhibit the
incidence and development of prostate cancer through vari-
ous mechanisms [16, 17]. The regulation of the apoptotic
pathways is one of the potential mechanisms that re-
sponsible for the beneficial effects of dietary omega-3
PUFA [18]. The increased apoptosis was observed fol-
lowing the treatment with a fish oil diet or DHA,
with the possible induction of both the intrinsic and
extrinsic apoptotic pathways [19]. The pro-apoptotic
effect of DHA has been reported to involve modifica-
tions of the expression and activity of different intra-
cellular apoptotic pathways [20, 21]. Therefore, to
better understand the potential apoptotic pathways
involved in DHA-induced apoptosis of prostate cancer
cells, pathway-focused gene expression analysis was
performed in our study using RT2 Profile PCR Arrays.
Methods
Cell culture and treatment
The human prostate carcinoma cell line DU145 was
purchased from the Shanghai cell bank of Chinese
Academy of Sciences (Shanghai, China). DU145 cells
were cultured in Dulbecco’s modified eagle medium
(DMEM, Gibico, Carlsbad, CA, USA) supplemented
with 10% fetal bovine serum (FBS, Hangzhou Sijiqing
Company, China), 100 U/mL penicillin and 0.1 mg/mL
streptomycin. Cells were incubated in a 5% CO2 incuba-
tor (Sanyo Electric Biomedical CO., LTD., Japan) at 37 °
C. The media were refreshed every 2–3 days. Fish oil
(Shanghai Haling biotechnology Co., Ltd., Shanghai,
China), DHA, eicosapentaenoic acid (EPA), and arachi-
donic acid (AA, 50 mmol/L, Sigma) were prepared using
NaOH and were dissolved in BSA (0.01 mol/L PBS, 1:9).
Media with and without BSA were used as BSA and
blank controls.
MTT assay
Cell viability was measured using an MTT kit (Sigma).
DU145 cells (200 μL, 2 × 104/mL) were seeded in 96-
well plates and synchronized by serum starvation in
DMEM containing 1% FBS for 24 h. The cells were then
incubated with fish oil at a final concentration of 50,
150, 250, and 500 μmol/L, or with AA, EPA, and DHA
at a final concentration of 10, 25, 50, and 100 μmol/L
for 24 h, respectively. Control cells were treated with
BSA (BSA group) or without any treatment (Blank con-
trol). MTT (5 mg/mL, 20 μL) was added to each well
and incubated for 4 h. The supernatants were removed
and dimethyl sulfoxide (150 μL, Sigma) was added. The
absorbance was measured at 490 nm using a DH5031
enzyme-linked immunometric meter (Nanjing Medical
Instrument Factory, China).
Hoechst staining
Cell apoptosis was determined by Hoechst staining.
DU145 cells (8 × 104) were plated in a 24-well plate and
incubated with DHA for 24 h. Cells were then fixed with
acetone for 30 min, followed by staining with Hoechst
33258 (Beyotime Institute of Biotechnology, Jiangsu,
China) for 15 min. Apoptosis of cells was assayed under
a fluorescent microscope (Olympus, Tokyo, Japan).
RT2 Profile PCR Arrays
DU145 cells treated with DHA were then underwent
pathway-focused gene expression analyses. Total RNA
was extracted with Trizol and was quantified by
NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies). First-strand cDNA was synthesized using
a RT2 first-strand kit (SABiosciences, Frederick, MD,
USA) according to the manufacturer’s instructions.
Pathway-focused gene expression analyses were
performed using RT2 Profile PCR Arrays (PAHS-012Z,
Qiagen, USA). The expressions of 84 key genes involved
in apoptosis-related pathways were measured.
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Real time quantitative polymerase chain reaction (RT-qPCR)
To validate the effect of DHA on expression of genes
that mediating the activity of apoptosis-related pathways,
RT-qPCR analysis was further performed. After treat-
ment of DU145 cells with different concentrations of
DHA for 24 h, total RNA was extracted and reverse
transcribed to cDNA. RT-qPCR was conducted using a
SYBR Green quantitative RT-PCR kit (Invitrogen,
Carlsbad, California). PCR program was 50 °C and 95 °C
each for 2 min followed by 40 cycles at 95 °C for 15 s
and 52 °C for 30 s. The primers used are summarized in
Table 1. Data were analyzed by 2−ΔΔCt method using
TBP as a reference gene.
Statistical analysis
Data were expressed as mean ± standard deviation (SD).
Statistical significance was analyzed using ANOVA
followed by least significant difference test or t test. All
statistical analysis was performed with SPSS, version17.0
(SPSS Inc., Chicago, IL, USA). A p value of less than
0.05 was considered as statistically significant.
Results
Effect of fish oil, AA, EPA, or DHA on DU145 cell viability
The viability of DU145 cells was determined by MTT
assay. As shown in Fig. 1a, after exposure with different
concentrations of fish oil for 24 h, viability of DU145
cells was significantly affected and showed a dose-
dependent decrease. Therefore, the effect of dose
dependent effect of AA, EPA, or DHA on viability of
DU145 cells was further investigated. AA exposure
showed no obvious effect on viability of DU145 cells
(Fig. 1b). By contrast, exposure of DU145 cells to EPA
and DHA significantly inhibited cell viability in a dose
dependent manner (Fig. 1c and d). The growth inhib-
ition of DHA was more pronounced than that of EPA.
Therefore, DHA was used in the following study. Time
dependent effect of DHA exposure on the viability of
DU145 cells was further evaluated with 50 μmol/L
DHA. As shown in Fig. 1e, growth inhibition-induced by
DHA was enhanced with the increased time.
Effect of DHA on DU145 cell apoptosis
Apoptosis of DU145 cells was evaluated following the
exposure of cells with DHA (50 μmol/L) for 24 h.
Morphological analysis using Hoechst 33258 stain showed
typical apoptotic characteristics of condensation and seg-
mentation of the nucleus after DHA exposure (Fig. 2).
Effect of DHA on apoptosis pathway-focused gene ex-
pression profiling
To gain insight of genes involving in DHA-induced
apoptosis, pathway-focused gene expression profiling of
DU145 cells was analyzed with the RT2 Profile PCR
Array System. The differentially expressed genes were
identified by fold changes greater than 2-folds. DU145
cells exposed to DHA showed an obviously different
gene expression pattern when compared with the con-
trol (Additional file 1: Table S1). Ten genes were identi-
fied to be upregulated greater than 2-folds after DHA
exposure, including three apoptosis-related cysteine
peptidases, caspase 1, 3 and 9, pro-apoptotic protein
BAX, cell death-inducing factors CIDEA and DFFA,
tumor necrosis related factors TNFRSF1A, LTA and
TNF, tumor suppressor gene TP53 (Table 2). Meanwhile,
5 genes were found to be downregulated at least 2-folds,
they were X-linked apoptosis inhibitor protein XIAP,
mitochondrion-associated apoptosis inducing factor
AIFM1, protein kinase AKT1, BH3-containing proteins
BID and BIRC6. To confirm the findings of our
Table 1 Primes used for RT-qPCR
Gene Prime Length (bp)
Caspase 3 Sense: 5’-TCTGGTTTTCGGTGGGTGT-3’ 287
Antisense:5’-TGAGGTTTGCTGCATCGACAT-3’
Caspase 1 Sense: 5’-ACATCCCACAATGGGCTCTG-3’ 233
Antisense:5’-TTCACTTCCTGCCCACAGAC-3’
Caspase 9 Sense: 5’-CAGGCCCCATATGATCGAGG-3’ 194
Antisense:5’-TCGACAACTTTGCTGCTTGC-3’
Caspase 12 Sense: 5’-ATCCAACGGTGTTCTGGTCC-3’ 360
Antisense:5’-TCTCGCATCCCCAAAAGGTC-3’
TNF Sense: 5’-CTGGGCAGGTCTACTTTGGG-3’ 272
Antisense:5’-CTGGAGGCCCCAGTTTGAAT-3’
TP53 Sense: 5’-ACCTATGGAAACTACTTCCTGAAA-3’ 500
Antisense:5’-ACCATCGCTATCTGAGCAGC-3’
BCL2 Sense: 5’-TTTGTGGAACTGTACGGCCC-3’ 451
Antisense: 5’-CGGTGCTTGGCAATTAGTGG-3’
CIDEA Sense: 5’-GTGCAGGCAGACAGACCTCC-3’ 487
Antisense: 5’-CTTCACGTTAAGGCAGCCGA-3’
DFFA Sense: 5’-TACGTCAGAGTTGTGCCACC-3’ 312
Antisense:5’-TGGTAACCAACTCCAAATCCTGA-3’
AIFM1 Sense: 5’-GTTCCAGCGATGGCATGTTC-3’ 230
Antisense: 5’-ACGCGGCCTTTTTCTGTTTC-3’
AKT1 Sense: 5’-CAGGAGGTTTTTGGGCTTGC-3’ 418
Antisense: 5’-TGTACTCCCCTCGTTTGTGC-3’
BID Sense: 5’-CATAAGGAGGAAGCGGGTAGTC-3’ 174
Antisense: 5’-ACCGTTGTTGACCTCACAGT-3’
AKT1 Sense: 5’-CAGCCTCCCTCCGAGTTTG-3’ 446
Antisense: 5’-ACCTGGTTTAGCACTGAGCG-3’
XIAP Sense: 5’-ATTTCCAGATTGGGGCTCGG-3’ 449
Antisense:5’-TTTGTAGACTGCGTGGCACT-3’
TBP Sense: 5’-CAGGGGTTCAGTGAGGTCG-3’ 107
Antisense: 5’-ACCCTGGGTCACTGCAAAG-3’
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pathway-focused gene expression analysis, the time-
dependent effect of DHA on some of the differentially
expressed genes were further assessed by RT-qPCR. As
shown in Fig. 3, DHA treatment for 24 h significantly
upregulated the expressions of caspase 1, 3 and 9, BAX,
CIDEA, DFFA, TNF and TP53, while downregulated the
expressions of XIAP, AIFM1, AKT1, BID and BIRC6
(p < 0.05). DHA treatment of DU145 cells showed a
time dependent effect on the expressions of Caspase
3 and 9, BAX, CIDEA, TNF, XIAP, AIFM1 and BID
(p < 0.05). These up- and down-regulated genes were
further subjected to KEGG pathway analyses. KEGG
pathway annotation showed that the targeted genes
were highly enriched in several pathways, mainly in-
volved in the P53 signaling pathway, MAPK signaling
pathway, TNF signaling pathway, PI3K/AKT signaling
pathway, and NF-κB signaling pathway (Table 3).
Discussion
Dietary fat consumption is a critical risk factor for devel-
opment and progression of prostate cancer [8, 22].
Omega-3 PUFA, particularly DHA, have shown import-
ant inverse associations with tumorigenesis and progres-
sion, with the inhibited cell proliferation and reduced
incidence and progression of the tumors [23, 24].
Alteration in apoptosis may play a crucial role in this
procedure [20, 25, 26]. However, the potential mecha-
nisms have not been fully elucidated [27]. The critical
analysis of PUFA action on potential apoptotic pathways
have been carried out in this study. The findings of our
study showed that DHA may modulate the apoptosis of
prostate cells through different pathways. DHA exposure
upregulated the gene expressions of Caspase 9, Caspase
3, DFFA, TP53, BAX, CIDEA, TNF, TNFRSF1A, Caspase
1, and LTA, while downregualted XIAP, AIFM1, BIRC6,
Fig. 1 Viability of human prostate cancer DU145 cells as determined by MTT assay. The dose dependent effect of fish oil (a), AA (b), EPA (c), and
DHA (d) on viability of DU145 cells. The time-dependent effect of DHA on cell viability (e). *p < 0.05 vs the control groups
Fig. 2 Effect of DHA exposure on apoptosis of DU145 cells assessed by Hoechst 33258 staining
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AKT1, and BID expressions. KEGG pathway annotation
showed that DHA exposure mainly involved in the p53
pathway, TNF signaling pathway, AKT-related signaling
pathway, and mitochondrial-related pathway, suggesting
the modulation of the both extrinsic and intrinsic apop-
totic pathways by DHA. Some of such pathways have
been reported in DHA-induced pro-apoptosis of cancer
cells [14, 28–30].
Previous studies indicated that increased dietary
intakes of omega-6 PUFA like AA may worsen the
development of prostate cancer. By contrast, intakes of
omega-3 PUFA, such as EPA and DHA, may improve
the development of prostate cancer [12]. A high dietary
ratio of n-6/n-3 fatty acids has been reported to increase
the risk of prostate cancer [7]. In our study, AA expos-
ure caused no obvious inhibition of proliferation of
DU145 cells. This was quietly different from the results
reported by Meng et al., which indicated that AA
supplementation (25, 50, 75, 100, 125, 150, 175 μmol/L)
resulted in significantly decreased viability of human
prostate cancer PC-3 cells [22]. This conflicting result
may be partially explained by the different concentration
gradients and prostate cell lines used. However, exposure
of DU145 cells to the EPA or DHA in our study mark-
edly reduced the cell viability, and this effect showed a
dose-dependent pattern. The more pronounced growth
inhibition of DHA was observed. Similar results have
been reported, which indicated that DHA was a tumor
reducing omega-3 PUFA for both androgen-dependent
and -independent prostate cancer cell lines (LNCaP cells
PC-3 cells) [22, 31, 32]. However, the study by Chung et
al. indicated that DHA treatment showed litter response
in androgen-dependent prostate cancer LNCaP cells
[33]. Schley et al. have reported that DHA was more po-
tent in growth inhibition of human breast cancer MDA-
MB-231 cells than that of EPA [24]. While Liu and col-
leagues showed more efficacious growth inhibition of
EPA than that of DHA [13]. The possible explanations
for this disparity could be the different doses and cell
lines used in these studies. Despite of these conflicting
results, our results did show a pronounced growth in-
hibitory effect of omega-3 PUFA, EPA and DHA, on
androgen-independent, hormone refractory prostate
cancer DU145 cells. DHA exposure caused a time-
dependent growth inhibition on DU145 cells. Further-
more, apoptosis of DU145 cells was also found to be sig-
nificantly enhanced following DHA treatment. All these
results showed evidence suggested that omega-3 PUFA,
particularly DHA, may exert beneficial effect on prostate
cancer through inhibiting proliferation and promoting
apoptosis of cancer cells.
The anticancer activity of omega 3-PUFA (DHA) has
been suggested to be due to apoptosis induction of fatty
acid [25, 34–36]. Different apoptotic pathways have been
reported to involve in the anticancer actions of omega-3
fatty acids (DHA). The p53-mediated signaling pathways
have been identified to involve in DHA-induced apop-
tosis and autophagy in cancer cells harboring wild-type
p53 [28]. In prostate cancer cells harboring mutant p53,
however, mitochondrial ROS-mediated Akt-mTOR
signaling was found to induce apoptosis and autophagy
[29]. DHA has also been shown to induce apoptosis
through inhibiting the Akt/NF-κB pathway and by modu-
lating the PI3K/AKT/p38 MAPK pathway [14, 24, 37, 38].
The suppression of genes involved in PDK1/Akt/Bad sig-
naling and NF-kB pathways has also been suggested to
Table 2 Effect of DHA on apoptosis pathway-focused gene expression profiling of DU145 cells
Refseq Symbol Description Folds
NM_001229 CASPASE 9 Caspase 9, apoptosis-related cysteine peptidase 12.10
NM_004346 CASPASE 3 Caspase 3, apoptosis-related cysteine peptidase 4.88
NM_004401 DFFA DNA fragmentation factor, 45 kDa, alpha polypeptide 3.21
NM_000546 TP53 Tumor protein p53 2.97
NM_004324 BAX BCL2-associated X protein 2.93
NM_001279 CIDEA Cell death-inducing DFFA-like effector a 2.34
NM_000594 TNF Tumor necrosis factor 2.24
NM_001065 TNFRSF1A Tumor necrosis factor receptor superfamily, member 1A 2.14
NM_033292 CASPASE 1 Caspase 1, apoptosis-related cysteine peptidase 2.06
NM_000595 LTA Lymphotoxin alpha (TNF superfamily, member 1) 2.04
NM_001167 XIAP X-linked inhibitor of apoptosis 0.49
NM_004208 AIFM1 Apoptosis-inducing factor, mitochondrion-associated, 1 0.45
NM_016252 BIRC6 Baculoviral IAP repeat containing 6 0.32
NM_005163 AKT1 V-akt murine thymoma viral oncogene homolog 1 0.21
NM_001196 BID BH3 interacting domain death agonist 0.11
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contribute to DHA-induced apoptosis [30, 39]. However,
the pro-apoptotic molecular mechanisms of DHA have not
been well established. Therefore, in the present study, the
apoptosis-related genes that abnormally expressed in
DHA-treated prostate cancer DU145 cells were screened
using the specifically designed RT2 Profile PCR arrays.
Among the 84 key genes involved in mediating apoptosis-
related pathways, 10 genes were more expressed in DHA-
exposed DU145 cells than control, while 5 genes were less
expressed following DHA exposure (more than two-fold
change). To confirm the accuracy of the present results,
RT-qPCR was performed to validate some of the differently
expressed genes in a time-dependent manner. The results
showed that the expressions of these differently expressed
genes were consistent with the data from microarray.
KEGG pathway analysis of our study showed that DHA
exposure may induce the apoptosis of cancer cells preferen-
tially through mediating P53, MAPK, TNF, PI3K/AKT, and
NF-κB signaling pathways, partially corroborating the
results of previous studies. However, future studies are still
needed to further clarify the molecular mechanisms of
DHA-induced proapoptosis of cancer cells.
Conclusions
In conclusion, our study demonstrated the beneficial
action of DHA on human prostate carcinoma cell line
DU145. The pro-apoptotic effect of DHA on DU145
cells may involve mediating P53 signaling pathway,
MAPK signaling pathway, TNF signaling pathway, PI3K/
AKT signaling pathway, and NF-κB signaling pathway.
Molecular mechanisms of DHA on apoptosis of cancer
cells still need further clarify.
Additional file
Additional file 1: Table S1. Apoptosis pathway-focused gene expression
profiling of DU145 cells following DHA exposure. (DOCX 21 kb)
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Fig. 3 RT-qPCR analysis of the time-dependent effect of DHA exposure
on differentially expressed genes identified by pathway-focused gene ex-
pression analysis. *p< 0.05 vs the BSA group
Table 3 Pathway enrich of apoptotic genes
Components Gene count Representative genes
P53 signaling pathway 6 Caspase 3, Caspase 9, TP53,
Bax, AKT1, BID
MAPK signaling pathway 5 Caspase 3, TP53, TNF,
TNFRSF1A, AKT1
TNF signaling pathway 4 Caspase 3, TNF, XIAP, AKT1
PI3K/AKT signaling pathway 2 Caspase 9, TP53
NF-κB signaling pathway 2 TNF, XIAP
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